Trial intelligence / Profile preview

IV Methylnaltrexone for Post-Operative Ileus

NCT01367548Phase 2Completed

Sponsor
Valeant Pharmaceuticals
Start
Jul 2003
Primary completion
Dec 2004
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of methylnaltrexone in postoperative ileus (POI), sponsored by Valeant Pharmaceuticals. Started Jul 2003; status: completed.

02

Drugs

methylnaltrexone
03

Conditions

postoperative ileus (POI)

Beyond the preview

Go deeper on NCT01367548.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01367548.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call